4.7 Article

Mir-34: A New Weapon Against Cancer?

期刊

MOLECULAR THERAPY-NUCLEIC ACIDS
卷 3, 期 -, 页码 -

出版社

CELL PRESS
DOI: 10.1038/mtna.2014.47

关键词

apoptosis; cancer; cell cycle; delivery; DNA damage; microRNA; miR-34a; multiple myeloma; nanotechnology; p53

资金

  1. Italian Association for Cancer Research (AIRC)
  2. Special Program Molecular Clinical Oncology-5 per mille [9980]

向作者/读者索取更多资源

The microRNA(miRNA)-34a is a key regulator of tumor suppression. It controls the expression of a plethora of target proteins involved in cell cycle, differentiation and apoptosis, and antagonizes processes that are necessary for basic cancer cell viability as well as cancer stemness, metastasis, and chemoresistance. In this review, we focus on the molecular mechanisms of miR-34a-mediated tumor suppression, giving emphasis on the main miR-34a targets, as well as on the principal regulators involved in the modulation of this miRNA. Moreover, we shed light on the miR-34a role in modulating responsiveness to chemotherapy and on the phytonutrients-mediated regulation of miR-34a expression and activity in cancer cells. Given the broad anti-oncogenic activity of miR-34a, we also discuss the substantial benefits of a new therapeutic concept based on nanotechnology delivery of miRNA mimics. In fact, the replacement of oncosuppressor miRNAs provides an effective strategy against tumor heterogeneity and the selective RNA-based delivery systems seems to be an excellent platform for a safe and effective targeting of the tumor.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据